Tammi M Short , FNP-C
Nurse Practitioner โข Longview, TX
3535 N Fourth St Ste 400
Longview, TX 756050038
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 9, 2006; this date does not establish years in practice.
-
Published CMS data list 5,342 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 1,718 service units.
- 99213 โ Established patient outpatient office visit: 1,470 service units.
- 17000 โ Destruction of precancer skin growth, 1 growth: 616 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,558 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Triamcinolone Acetonide โ 174 prescription fills, including refills.
- Doxycycline Hyclate โ 172 prescription fills, including refills.
- Ketoconazole โ 144 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under Nurse Practitioner in Longview, TX (2024, 28 clinicians with data). Median for this group: 669. Middle half: 274 to 1,833.
More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Texas (2024, 1,852 clinicians with data). Median for this group: 219. Middle half: 83 to 548.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,459 in 2020 to 5,342 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
3535 N Fourth St Ste 400
Longview, TX 756050038
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Wallis Dermatology Associates Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Texas Tech University Health Science Center School Of Medicine
2002
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,155 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $266,287 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $180,754 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
1,912 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$356,980 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $3,288.10 across 168 records.
By nature of payment
- Food and Beverage: $3,117.47 across 165 records.
- Education: $170.63 across 3 records.
Reporting-company totals (3 largest of 18)
- ABBVIE INC.: $423.19 across 32 records.
- Sanofi and Genzyme US Companies: $415.34 across 16 records.
- UCB, Inc.: $375.34 across 18 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
24 years (graduated 2002)
CMS Doctors and Clinicians data list 2002 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Tammi Short has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Tammi Short as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Longview and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under Nurse Practitioner in Longview, TX (2024, 28 clinicians with data). Median for this group: 669. Middle half: 274 to 1,833.
More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Texas (2024, 1,852 clinicians with data). Median for this group: 219. Middle half: 83 to 548.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Nurse Practitioner in Longview, TX (2024, 28 clinicians with data). Median for this group: $42,949. Middle half: $17,138 to $92,944.
A higher Medicare-allowed amount than 95% of clinicians listed under Nurse Practitioner in Texas (2024, 1,852 clinicians with data). Median for this group: $17,068. Middle half: $6,758 to $39,305.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Nurse Practitioner in Longview, TX (2024, 28 clinicians with data). Median for this group: $32,700. Middle half: $11,990 to $68,958.
A higher Medicare payment amount than 95% of clinicians listed under Nurse Practitioner in Texas (2024, 1,852 clinicians with data). Median for this group: $12,638. Middle half: $4,849 to $28,908.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Longview, TX (2024, 26 clinicians with data). Median for this group: 478. Middle half: 152 to 1,510.
More Part D prescriptions than 80% of clinicians listed under Nurse Practitioner in Texas (2024, 2,095 clinicians with data). Median for this group: 274. Middle half: 77 to 1,097.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Nurse Practitioner in Longview, TX (2024, 26 clinicians with data). Median for this group: $17,052. Middle half: $1,382 to $244,905.
A higher Part D drug cost than 85% of clinicians listed under Nurse Practitioner in Texas (2024, 2,095 clinicians with data). Median for this group: $12,936. Middle half: $998 to $118,416.
49 active clinicians are listed under Nurse Practitioner with a practice address in Longview, TX (4,835 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Longview
10.2% of these 49 clinicians have the CMS telehealth indicator.
65.3% of these 49 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 54% from 3,459 in 2020 to 5,342 in 2024.
- 2020: 3,459
- 2021: 3,755
- 2022: 4,254
- 2023: 4,627
- 2024: 5,342
-
Medicare-allowed amount
Medicare-allowed amount increased 82% from $146,468 in 2020 to $266,287 in 2024.
- 2020: $146,468
- 2021: $195,302
- 2022: $204,236
- 2023: $223,408
- 2024: $266,287
-
Paid by Medicare
Paid by Medicare increased 87% from $96,725 in 2020 to $180,754 in 2024.
- 2020: $96,725
- 2021: $135,416
- 2022: $139,190
- 2023: $153,693
- 2024: $180,754
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 49% from 1,044 in 2020 to 1,558 in 2024.
- 2020: 1,044
- 2021: 999
- 2022: 1,044
- 2023: 1,335
- 2024: 1,558
-
30-day fills
30-day fills increased 66% from 1,152 in 2020 to 1,912 in 2024.
- 2020: 1,152
- 2021: 1,131
- 2022: 1,149
- 2023: 1,502
- 2024: 1,912
-
Part D drug cost
Part D drug cost increased 54% from $231,744 in 2020 to $356,980 in 2024.
- 2020: $231,744
- 2021: $271,430
- 2022: $500,631
- 2023: $594,948
- 2024: $356,980
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 183% from $1,163.09 in 2021 to $3,288.10 in 2025.
- 2021: $1,163.09
- 2022: $1,769.15
- 2023: $1,931.49
- 2024: $2,644.82
- 2025: $3,288.10
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 168 records totaling $3,288.10.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Edwards Lifesciences Corporation |
Food and Beverage
In-kind items and services
|
SAPIEN 3 Ultra RESILIA | General | $100.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Education
In-kind items and services
|
โ | General | $99.99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Education
In-kind items and services
|
โ | General | $60.99 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $51.78 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.57 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.68 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $37.18 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.14 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.73 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.46 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
โ | General | $34.91 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.77 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
โ | General | $33.18 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $31.61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $31.47 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.46 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $30.02 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.11 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.92 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.92 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.70 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.35 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.27 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
1,718 | 328 | $33.00 | $5.33 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,470 | 970 | $175.00 | $73.70 |
|
17000
Destruction of precancer skin growth, 1 growth
|
616 | 460 | $160.00 | $41.70 |
|
17110
Destruction of skin growth, 1-14 growths
|
456 | 365 | $270.00 | $87.17 |
|
11102
Biopsy of related skin growth, first growth
|
210 | 177 | $245.00 | $68.21 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
188 | 116 | $250.00 | $104.01 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
109 | 109 | $225.00 | $90.87 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
108 | 29 | $10.00 | $0.99 |
|
11301
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
|
79 | 70 | $288.00 | $87.62 |
|
17111
Destruction of skin growth, 15 or more growths
|
61 | 52 | $315.00 | $105.44 |
|
11300
Shaving of skin growth of body, arms, or legs, 0.5 cm or less
|
51 | 42 | $245.00 | $52.88 |
|
11302
Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
|
38 | 37 | $320.00 | $108.80 |
|
11103
Biopsy of related skin growth, each additional growth
|
37 | 29 | $130.00 | $40.37 |
|
11311
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
|
37 | 36 | $330.00 | $107.02 |
|
11900
Injection into skin growth, 1-7 growths
|
35 | 18 | $135.00 | $41.67 |
|
11310
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
|
31 | 25 | $280.00 | $79.57 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
31 | 27 | $430.00 | $134.89 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
20 | 18 | $423.00 | $133.42 |
|
96372
Injection of drug or substance under skin or into muscle
|
20 | 15 | $51.00 | $11.62 |
|
11306
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
|
15 | 15 | $360.00 | $91.85 |
|
11312
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
|
12 | 11 | $382.00 | $120.05 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone Acetonide | 174 | 5,152 | $2,341.93 | 125 |
| Doxycycline Hyclate | Doxycycline Hyclate | 172 | 6,329 | $3,491.10 | 83 |
| Ketoconazole | Ketoconazole | 144 | 3,779 | $2,432.50 | 76 |
| Clobetasol Propionate | Clobetasol Propionate | 112 | 2,933 | $4,258.70 | 60 |
| Mometasone Furoate | Mometasone Furoate | 107 | 2,636 | $2,200.78 | 59 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 102 | 2,585 | $3,743.42 | 64 |
| Clindamycin Phosphate | Clindamycin Phosphate | 86 | 2,425 | $4,712.05 | 38 |
| Hydrocortisone | Hydrocortisone | 85 | 2,024 | $623.26 | 60 |
| Minoxidil | Minoxidil | 68 | 5,096 | $528.03 | 25 |
| Metronidazole | Metronidazole | 63 | 1,826 | $3,928.62 | 39 |
| Methotrexate | Methotrexate Sodium | 57 | 2,003 | $405.66 | โ |
| Dupixent Pen | Dupilumab | 38 | 1,232 | $170,921.19 | โ |
| Nystatin | Nystatin | 37 | 879 | $449.10 | 26 |
| Spironolactone | Spironolactone | 37 | 2,610 | $683.92 | 11 |
| Mupirocin | Mupirocin | 36 | 534 | $310.95 | 30 |
| Cephalexin | Cephalexin | 32 | 719 | $362.03 | 16 |
| Minocycline Hcl | Minocycline Hcl | 28 | 1,301 | $704.01 | 12 |
| Valacyclovir | Valacyclovir Hcl | 23 | 1,144 | $803.40 | โ |
| Humira(Cf) Pen | Adalimumab | 22 | 616 | $150,629.48 | โ |
| Prednisone | Prednisone | 20 | 235 | $42.67 | 18 |
| Ciclopirox | Ciclopirox | 19 | 630 | $514.95 | 13 |
| Fluconazole | Fluconazole | 18 | 437 | $149.21 | 15 |
| Terbinafine Hcl | Terbinafine Hcl | 18 | 1,144 | $196.15 | 12 |
| Tetracycline Hcl | Tetracycline Hcl | 14 | 540 | $840.22 | โ |
| Clindamycin-Benzoyl Peroxide | Clindamycin Phos/Benzoyl Perox | 12 | 360 | $768.34 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-03-04NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20040809000211
TX
1456323773
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Wallis Dermatology Associates Pllc
1900 S Washington Ave, Marshall, TX 756706845
Phone: 9035037330
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Nurse Practitioner
Advanced Practice Registered Nurse - Certified Nurse Practitioner
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Physician Assistant
Physician Assistant
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3535 N FOURTH ST STE 400, LONGVIEW, TX 756050038 (Tel: 9037573881)
Registered at 3535 N FOURTH ST STE 400, LONGVIEW, TX 756050038 (Tel: 9037573881)
Registered at 1111 N 6TH ST, LONGVIEW, TX 756015537 (Tel: 9032363266)
NPI status registered as active in NPPES database
Registered at 703 E MARSHALL AVE, STE 3005, LONGVIEW, TX 756015500 (Tel: 9032363266)
Registered at #6 DOCTOR CIRCLE, LONGVIEW, TX 756055500 (Tel: 9032363266)
Recorded as TAMMI SHORT, FNP-C
Nurse Practitioner (license number reported to NPPES: TX 608154)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Longview
- Ashley Tunstall, FNP
- Jennifer Williams, APRN
- Melissa Sutton, ANP
- Stephanie Silverman, FNP-C
- Ashley Quitugua, NP
- Sara Hale
Mailing Address
3535 N Fourth St Ste 400
Longview, TX 756050038
Phone: 9037573881